Abstract:Aims The transcription factor NRF2 is well recognized as a master regulator of antioxidant responses and cytoprotective genes. Previous studies showed that NRF2 enhances resistance of mouse hearts to chronic hemodynamic overload at least in part by reducing oxidative stress. Evidence from other tissues suggests that NRF2 may modulate glucose intermediary metabolism but whether NRF2 has such effects in the heart is unclear. Here, we investigate the role of NRF2 in regulating glucose intermediary metabolism and cardiac function during disease stress. Methods and Results Cardiomyocyte-specific Keap1 knockout (csKeap1KO) mice, deficient in the endogenous inhibitor of NRF2, were used as a novel model of constitutively active NRF2 signaling. Targeted metabolomics and isotopomer analysis were employed in studies with 13C6-glucose in csKeap1KO and wild-type (WT) mice. Pharmacological and genetic approaches were utilized in neonatal rat ventricular cardiomyocytes (NRVM) to explore molecular mechanisms. We found that cardiac-specific activation of NRF2 redirected glucose metabolism towards the pentose phosphate pathway (PPP), a branch pathway of glycolysis, and mitigated pressure overload-induced cardiomyocyte death and cardiac dysfunction. Activation of NRF2 also protected against myocardial infarction-induced DNA damage in remote myocardium and cardiac dysfunction. In vitro, knockdown of Keap1 upregulated PPP enzymes and reduced cell death in NRVM subjected to chronic neurohumoral stimulation. These pro-survival effects were abolished by pharmacological inhibition of the PPP or silencing of the PPP rate-limiting enzyme glucose-6-phosphate dehydrogenase (G6PD). Knockdown of NRF2 in NRVM increased stress-induced DNA damage which was rescued by supplementing the cells with either NADPH or nucleosides, the two main products of the PPP. Conclusions These results indicate that NRF2 regulates cardiac metabolic reprogramming by stimulating the diversion of glucose into the PPP, thereby generating NADPH and providing nucleotides to prevent stress-induced DNA damage and cardiac dysfunction.

Nrf2 at the heart of oxidative stress and cardiac protection

Nrf2 for cardiac protection: pharmacological options against oxidative stress

Targeting the Nrf2 Pathway Against Cardiovascular Disease

Nrf2 Protects Against Maladaptive Cardiac Responses to Hemodynamic Stress

Nrf2 enhances myocardial clearance of toxic ubiquitinated proteins

Nrf2 and cardiovascular defense

The role of Nrf2 in carcinogenesis

The role of Nrf2 in oxidative stress-induced endothelial injuries

Induction of Cardiac Pathology: Endogenous versus Exogenous Nrf2 Upregulation

Nrf2 for a key member of redox regulation: A novel insight against myocardial ischemia and reperfusion injuries

Nrf2-Keap1 in Cardiovascular Disease: Which is the Cart and Which the Horse?

The Role of the Nrf2/ARE Antioxidant System in Preventing Cardiovascular Diseases

Nrf1 promotes heart regeneration and repair by regulating proteostasis and redox balance

Role of Nrf2in neuroprotection and its mechanisms

NRF2 activation in the heart induces glucose metabolic reprogramming and reduces cardiac dysfunction via upregulation of the pentose phosphate pathway

Enhanced Keap1-Nrf2 signaling protects the myocardium from isoproterenol-induced pathological remodeling in mice

Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway

Diabetic cardiomyopathy and its prevention by nrf2: current status.

The Nrf-2/HO-1 Signaling Axis: A Ray of Hope in Cardiovascular Diseases

The Role of Nrf2-Mediated Pathway in Cardiac Remodeling and Heart Failure

Regulation of Nrf2 by Mitochondrial Reactive Oxygen Species in Physiology and Pathology